Core Viewpoint - Nanjing Central Mall (Group) Co., Ltd. has been named by regulators for failing to disclose significant litigation developments in a timely manner, leading to inaccurate financial reporting for the first half of 2025 [1][2]. Group 1: Regulatory Actions - The Jiangsu Securities Regulatory Bureau issued an administrative regulatory measure against the company and relevant responsible persons, resulting in a warning letter being placed in the securities and futures market integrity file [1]. - The Shanghai Stock Exchange also announced a regulatory warning against the company and the responsible individuals on the same evening [1]. Group 2: Litigation Details - The company disclosed on July 13, 2024, that its subsidiary, Xuzhou Central Department Store Co., Ltd., was involved in a lawsuit with Xuzhou Xulai Cultural Communication Co., Ltd. over a rental contract dispute, with the amount in question being approximately 8.7977 million yuan [1]. - On October 30, 2025, the company provided a supplemental disclosure regarding the litigation progress, stating that a first-instance judgment was received on July 2, 2025, and an appeal was filed on July 16, 2025, with mediation reached on October 24, 2025 [2]. Group 3: Compliance and Impact - Industry experts emphasized the importance of timely disclosure of significant litigation developments to protect investors' rights, noting that the company delayed its disclosure by nearly four months, which is a serious violation of the "timeliness" principle [2]. - Legal professionals indicated that negative records in the integrity file could impact the management's future qualifications for positions in listed and non-listed public companies, as regulatory bodies scrutinize such records during appointment reviews [2].

天眼查资料显示，嘉应制药成立于2003年03月07日，注册资本50750.9848万人民币，法定代表人李能，注册地址为广东省梅州市东升工业园B区。主营业务 为中成药的研发、生产和销售。 雷达财经 文|杨洋 编|李亦辉 11月21日，广东嘉应制药股份有限公司（证券简称：嘉应制药，证券代码：002198）公告，公司因存在关联方非经营性资金往来未依法履行关联交易审议程 序及未及时披露的行为，涉及金额21,999万元，占公司最近一期经审计净资产的28.83%，被中国证监会广东监管局处以警告及罚款。 其中，公司被罚款150万元，董事长李能被罚160万元，总经理游永平被罚100万元，时任财务总监史俊平被罚80万元。 公司表示此次处罚不触及重大违法强制退市情形，生产经营正常，并向投资者致歉。 目前，公司董事长为李能，董秘为孙俊，员工人数为594人。 公司参股公司6家，包括广东嘉惠融资租赁有限公司、湖南金沙药业有限责任公司、广东嘉应医药有限公司、嘉应（深圳）大健康发展有限公司、广东康慈 医疗管理有限公司等。 在业绩方面，公司2022年、2023年、2024年和2025年前三季度营业收入分别为6.59亿元、5.33亿元、3.7 ...

Core Viewpoint - Koson Technology has been found to have multiple regulatory violations, leading to warnings and criticisms from regulatory bodies, which may impact its reputation and operations [1][4]. Group 1: Regulatory Violations - Koson Technology engaged in daily sales transactions with three related parties from 2018 to 2024 without following proper review procedures and disclosure obligations, only supplementing disclosures in April 2025 with errors in the reported amounts [1]. - In 2022, Koson Technology made non-operating fund occupations by transferring funds to a related party under the guise of sales transactions, with individual occupation periods ranging from 1 to 4 days, which were not disclosed as required [1]. - A former director, Li Jin, was placed under judicial supervision in January 2024 for suspected bribery but failed to disclose this investigation, only resigning after receiving a criminal judgment in July 2025 [1]. Group 2: Accountability and Consequences - The Jiangsu Securities Regulatory Bureau identified key responsibilities for the violations, holding former Chairman Xu Jingen and former CFO Xiang Xuemei primarily accountable for the related transactions and fund occupations [1]. - Former director Qu Liping is also held responsible for the violations related to the transactions, while Li Jin faces separate accountability for concealing the investigation [1]. - Koson Technology is required to submit a rectification report within 10 working days, and the Shanghai Stock Exchange has issued public criticisms against the company and its former executives, which will be recorded in the securities market integrity database [1][4]. Group 3: Company Response - Koson Technology has acknowledged the regulatory issues and plans to enhance its understanding of securities laws and regulations, as well as improve its information disclosure management and internal controls [2]. - The company emphasizes that the regulatory measures will not affect its normal production and operations, urging investors to make rational decisions [2].

Core Points - Jia Ying Pharmaceutical received an administrative penalty from the China Securities Regulatory Commission for illegal information disclosure and related party transactions [1][2][3] - The company and its chairman, Li Neng, were involved in short-term fund lending to a related party, Yao Juneng, without proper disclosure and approval [1][2] - The company reported a significant decline in revenue and net profit over the past two years, with 2024 revenue dropping by 29.46% year-on-year [3][4] Group 1: Regulatory Actions - Jia Ying Pharmaceutical was fined 1.5 million yuan, while Li Neng was fined 1.6 million yuan, totaling 4.9 million yuan in penalties for the violations [2] - The Guangdong Securities Regulatory Bureau issued a warning letter to the company for failing to disclose financial assistance and related party transactions [2][3] - The company acknowledged the violations and committed to enhancing compliance awareness [2] Group 2: Financial Performance - In 2024, Jia Ying Pharmaceutical's revenue was 37.6 million yuan, a decrease of 29.46% year-on-year, and the net profit dropped by 39.94% to 20.61 million yuan [3] - The company's gross margin fell from 75.31% in 2021 to 59.93% in 2024, indicating a declining profitability trend [3] - For the first three quarters of 2025, the company reported a revenue of 29.3 million yuan, a year-on-year increase of 13.0%, and a net profit of 21.79 million yuan, a significant increase of 658.5% [3][4]

Mergers and Acquisitions - Kaizhong Co., Ltd. is planning to acquire control of Anhui Tuosheng Automotive Parts Co., Ltd. through a combination of issuing shares and cash payment, with funds raised from no more than 35 specific investors to be used entirely for the transaction [1] - Yingli Co., Ltd. intends to purchase 100% equity of Foshan Zhiqiang Optoelectronics Co., Ltd. for 66.497 million yuan to enter the supply chain of a North American brand [2] - Gaoneng Environment is set to jointly invest with related parties to acquire 45.2% equity in three mining companies for a total of 82.6 million yuan, with the transaction amount for equity transfer being 63.28 million yuan [3] Shareholding Changes - Fujirui's shareholder, Shanghai Zhaoren, plans to reduce its stake by up to 0.21%, equating to 160,500 shares, due to personal funding needs, with the reduction period set from November 27, 2025, to February 26, 2026 [4] - Zhaoyi Innovation's executives plan to collectively reduce their holdings by 249,000 shares, with specific reductions from various executives ranging from 3,060 to 63,800 shares [5] - Juneyao Airlines' controlling shareholder, Shanghai Juneyao Group, intends to reduce its stake by up to 3%, amounting to 65.52 million shares, due to business arrangements from December 15, 2025, to March 14, 2026 [6] Regulatory Issues - Jushi Chemical has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure, having received a notice of investigation on November 21, 2025 [7] - Haosai has also been investigated by the China Securities Regulatory Commission for similar information disclosure violations, with the company stating that its operations remain normal [8] - Guolian Aquatic Products received a warning letter from the Guangdong Securities Regulatory Bureau for failing to disclose non-operating fund occupation of 7.8 million yuan in a timely manner, which was only reported in the annual report on April 28, 2025 [9]

Core Viewpoint - Kosun Technology has been involved in undisclosed related party transactions exceeding 2.5 billion yuan over several years, leading to regulatory scrutiny and disciplinary actions from the Shanghai Stock Exchange and Jiangsu Securities Regulatory Bureau [1][2]. Group 1: Regulatory Findings - The violations by Kosun Technology include failure to disclose related party transactions with companies such as Weishida and Yingzhirong from 2018 to 2024, with errors in the reported transaction amounts [2][3]. - Kosun Technology made non-operating fund usages amounting to 57.1 million yuan in January 2022, with the funds being occupied for 1 to 4 days without disclosure [2][7]. - A former director, Li Jin, was involved in a bribery case and concealed this information during board elections, only resigning after receiving a criminal judgment [2][3]. Group 2: Transaction Details - Kosun Technology acknowledged related party transactions totaling 1.44 billion yuan with Weishida, 970 million yuan with Yingzhirong, and 153 million yuan with Kesheng Catering from 2020 to 2024 [3][4]. - The company attributed the lack of timely disclosure to discrepancies between actual shareholders and those registered, as well as insufficient knowledge among executives regarding related parties [3][4]. - The actual control of Weishida was found to be held by Xu Jingen, who was not listed as a shareholder in public records [3][6]. Group 3: Company Structure and Relationships - The actual control of Yingzhirong was linked to former director Qu Liping, who held shares through a proxy arrangement, and the financial director's spouse also had a stake in the company [4][5]. - The actual controller of Kesheng Catering is related to the actual controller of Kosun Technology, indicating a complex web of relationships [5][6].

【导读】涉嫌信息披露违法违规，豪尔赛被证监会立案调查 中国基金报记者 李智 11 月 21 日， 豪尔赛 公告称， 因涉嫌信息披露违法违规，中国证监会对公司进行立案。 此 前，因涉嫌单位行贿罪，豪尔赛控股股东、实际控制人戴宝林被公安机关执行逮捕，公司因 涉嫌单位行贿罪被监察机关立案调查。 豪尔赛被立案调查 11 月 21 日，豪尔赛发布公告称，公司近日收到中国证监会下发的《立案告知书》，因涉嫌 信息披露违法违规，中国证监会对公司进行立案。 豪尔赛表示，公司将积极配合调查工作，目前各项经营活动正常有序开展，本次立案不会对 公司经营和管理造成重大影响。 因涉嫌单位行贿罪 实控人被公安机关执行逮捕 自去年 12 月份开始，豪尔赛便笼罩在负面信息的阴影之下。 2024 年 12 月 12 日，武汉市新洲区监察委员会对时任豪尔赛董事长、总经理戴宝林涉嫌违 法犯罪进行立案调查，并对其实施留置。 2025 年 4 月 22 日，武汉市新洲区监察委员会解 除对戴宝林的留置。 2025 年 6 月 19 日，武汉市公安局新洲区分局对戴宝林执行逮捕。 2025 年 8 月 7 日，豪尔赛收到湖北省武汉市新洲区人民检察院《起诉书》 ...

Core Points - Haosai has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure regulations [2][4] - The company's actual controller, Dai Baolin, has been arrested for alleged unit bribery, leading to further scrutiny of the company's operations [5][6] Group 1: Investigation Details - On November 21, Haosai announced it received a notice of investigation from the CSRC due to suspected information disclosure violations [2] - The investigation follows Dai Baolin's arrest by public security authorities for alleged unit bribery, which has raised concerns about the company's governance and internal controls [5][6] Group 2: Company Operations - Haosai stated that it will actively cooperate with the investigation and that its business operations are currently normal and orderly [4] - The company has been under negative scrutiny since December of the previous year, with regulatory bodies highlighting deficiencies in its information disclosure practices [5][6] Group 3: Regulatory Actions - The Beijing Securities Regulatory Bureau issued a warning letter to Haosai for failing to fulfill its information disclosure obligations [6][7] - The Shenzhen Stock Exchange also sent a regulatory letter to Haosai and its responsible personnel, urging strict compliance with relevant laws and regulations regarding information disclosure [8] Group 4: Company Profile - Haosai's main business includes precision stamping molds and metal structural components for new energy vehicles, fuel vehicles, energy storage equipment, and communication devices [8] - As of November 21, Haosai's stock price was reported at 16.21 yuan per share, with a total market value of 2.437 billion yuan [8]

科森科技上述行为违反了《上市公司信息披露管理办法》(证监会令第40号，以下简称2007年《信披办 法》)第二条第一款、第四十八条，《上市公司信息披露管理办法》(证监会令第182号，以下简称2021 年《信披办法》)第三条第一款、第四十一条的规定。公司时任董事长、总经理徐金根，时任财务总 监、副总经理、董事向雪梅，时任董事瞿李平未勤勉尽责，对该事项负有主要责任。 2022年，科森科技以购销往来款名义向唯士达支付资金并于当期收回，构成关联方非经营性资金占用， 单笔资金占用周期1至4天。科森科技未按相关规定履行审议程序和信息披露义务，违反了2021年《信披 办法》第三条第一款、第四十一条的规定。科森科技时任董事长、总经理徐金根，时任财务总监、副总 经理、董事向雪梅未勤勉尽责，对该事项承担主要责任。 智通财经APP讯，科森科技(603626.SH)发布公告，公司及相关人员于2025年11月21日收到中国证券监督 管理委员会江苏监管局(以下简称"江苏证监局")下达的《江苏证监局关于对昆山科森科技股份有限公 司、徐金根、向雪梅、瞿李平采取出具警示函措施的决定》，内容公告如下： 2018年至2024年，科森科技与关联方江苏 ...

蓝鲸新闻11月21日讯，近日，深圳证监局发布了一则行政监管措施决定书，剑指深圳市汇诚行信息科技股份有限公司及时任董事长王德平。 根据决定书，深圳市汇诚行信息科技股份有限公司未按期披露2024年年度报告，违反了《非上市公众公司信息披露管理办法》的相关规定。时 任董事长王德平作为公司信息披露事务负责人，未忠实、勤勉地履行职责，对公司上述违规行为负有主要责任。 深圳证监局根据相关规定，决定对深圳市汇诚行信息科技股份有限公司及王德平采取出具警示函的监管措施，并记入证券期货市场诚信档案。 | 索 引 号 | bm56000001/2025- 00013409 | 分 类 | | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | 1763683903000 | | 名 称 | | 深圳证监局关于对深圳市汇诚行信息科技股份有限公司及王德平采取出具警示函措施的 伏正 | | | 文 륵 | 行政监管措施决定书 〔2025〕 229号 | 主题词 | | ...